Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.

Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2035-42.

2.

The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts.

Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino GA, Hyland A, Sweanor D, Warner KE, Compton C.

Addict Behav. 2006 Jul;31(7):1190-200. Epub 2005 Oct 26.

PMID:
16256276
3.

Tobacco control policies and the concurrent use of smokeless tobacco and cigarettes among men, 1992-2002.

Mumford EA, Levy DT, Gitchell JG, Blackman KO.

Nicotine Tob Res. 2005 Dec;7(6):891-900.

PMID:
16298724
4.
5.

Health risks of smoking compared to Swedish snus.

Daniel Roth H, Roth AB, Liu X.

Inhal Toxicol. 2005 Dec 1;17(13):741-8. Review.

PMID:
16195209
6.

Should Australia lift its ban on low nitrosamine smokeless tobacco products?

Gartner CE, Hall WD.

Med J Aust. 2008 Jan 7;188(1):44-6.

PMID:
18205564
7.

Snuffing out cigarette sales and the smoking deaths epidemic.

Laugesen M.

N Z Med J. 2007 Jun 15;120(1256):U2587. Review.

PMID:
17589555
8.

Smokeless tobacco: a gateway to smoking or a way away from smoking.

Melikian AA, Hoffmann D.

Biomarkers. 2009 Jul;14 Suppl 1:85-9. doi: 10.1080/13547500902965401. Review.

PMID:
19604066
9.

Smokeless tobacco.

Pershagen G.

Br Med Bull. 1996 Jan;52(1):50-7.

10.

You might as well smoke; the misleading and harmful public message about smokeless tobacco.

Phillips CV, Wang C, Guenzel B.

BMC Public Health. 2005 Apr 5;5:31.

11.

Tobacco use, cancer causation and public health impact.

Kuper H, Adami HO, Boffetta P.

J Intern Med. 2002 Jun;251(6):455-66. Review.

12.

Changing smokeless tobacco products new tobacco-delivery systems.

Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS.

Am J Prev Med. 2007 Dec;33(6 Suppl):S368-78. Review.

PMID:
18021912
13.

Smokeless tobacco and oral cancer: a review of the risks and determinants.

Rodu B, Jansson C.

Crit Rev Oral Biol Med. 2004 Sep 1;15(5):252-63. Review.

14.

Harm reduction policies for tobacco users.

Gartner C, Hall W.

Int J Drug Policy. 2010 Mar;21(2):129-30. doi: 10.1016/j.drugpo.2009.10.008. Epub 2009 Nov 26.

PMID:
19944582
15.

Smokeless tobacco: challenges, products and, cessation.

Rankin KV, Jones DL, Benton E.

Tex Dent J. 2010 Jun;127(6):589-94.

PMID:
20629366
16.
18.

Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.

Mendoza-Baumgart MI, Tulunay OE, Hecht SS, Zhang Y, Murphy S, Le C, Jensen J, Hatsukami DK.

Nicotine Tob Res. 2007 Dec;9(12):1309-23.

PMID:
18058349
19.

University faculty perceptions of the health risks related to cigarettes and smokeless tobacco.

Peiper N, Stone R, van Zyl R, Rodu B.

Drug Alcohol Rev. 2010 Mar;29(2):121-30. doi: 10.1111/j.1465-3362.2009.00143.x.

PMID:
20447218
20.

Smokeless tobacco use among adult patients who visited family practice clinics in Karachi, Pakistan.

Ali NS, Khuwaja AK, Ali T, Hameed R.

J Oral Pathol Med. 2009 May;38(5):416-21.

PMID:
19434816
Items per page

Supplemental Content

Write to the Help Desk